156 related articles for article (PubMed ID: 38172491)
1. Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer.
Ohashi K; Nishito Y; Fukuda H; Sadahiro R; Yoshida Y; Watanabe SI; Motoi N; Sonobe Y; Mizuno H; Tsunoda H; Tatsumi K; Suzuki T; Ochiai A; Aoki K
Sci Rep; 2024 Jan; 14(1):429. PubMed ID: 38172491
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
[TBL] [Abstract][Full Text] [Related]
3. Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
World J Surg Oncol; 2015 Sep; 13():291. PubMed ID: 26424708
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating neutrophils and peripheral neutrophil-to-lymphocyte ratio conversely predicted the prognosis of patients with non-small cell lung cancer.
Yang R; Wang X; Ma C; Zhang Z; Liu N; Ma X; Zhang Y; Wang X; Liu Y
Cell Immunol; 2022 Sep; 379():104588. PubMed ID: 35961201
[TBL] [Abstract][Full Text] [Related]
7. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.
Suh KJ; Kim SH; Kim YJ; Kim M; Keam B; Kim TM; Kim DW; Heo DS; Lee JS
Cancer Immunol Immunother; 2018 Mar; 67(3):459-470. PubMed ID: 29204702
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
[TBL] [Abstract][Full Text] [Related]
11. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
Shirasawa M; Yoshida T; Horinouchi H; Kitano S; Arakawa S; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Kanda S; Watanabe R; Yamamoto N; Watanabe SI; Ohe Y; Motoi N
Br J Cancer; 2021 Mar; 124(5):925-932. PubMed ID: 33250511
[TBL] [Abstract][Full Text] [Related]
13. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
14. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?
Unal D; Eroglu C; Kurtul N; Oguz A; Tasdemir A
Asian Pac J Cancer Prev; 2013; 14(9):5237-42. PubMed ID: 24175807
[TBL] [Abstract][Full Text] [Related]
15. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
16. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study.
Samejima H; Kojima K; Fujiwara A; Tokunaga T; Okishio K; Yoon H
BMC Cancer; 2023 Nov; 23(1):1107. PubMed ID: 37964220
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
18. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
Wang X; Li K
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
[TBL] [Abstract][Full Text] [Related]
19. Elevation of Neutrophil-to-Lymphocyte Ratio Is a Significant Poor Prognostic Factor in Completely Resected Centrally Located Lung Squamous Cell Carcinoma.
Tsukioka T; Izumi N; Komatsu H; Inoue H; Ito R; Suzuki S; Nishiyama N
In Vivo; 2022; 36(5):2303-2307. PubMed ID: 36099121
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]